{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,9,26]],"date-time":"2025-09-26T00:11:59Z","timestamp":1758845519746,"version":"3.44.0"},"reference-count":15,"publisher":"BMJ","issue":"11","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["J Clin Pathol"],"published-print":{"date-parts":[[1993,11]]},"abstract":"<jats:p>AIMS--To evaluate the fibronectin concentrations in the cerebrospinal fluid of HIV-1 infected patients with central nervous system disorders. METHODS--Fibronectin was determined by an immunoturbidimetric assay in 41 HIV-1 infected patients with AIDS dementia complex, progressive multifocal leucoencephalopathy, and opportunistic infections. RESULTS--A significant decrease in fibronectin concentrations in the cerebrospinal fluid of patients with AIDS and dementia complex and progressive multifocal leucoencephalopathy was observed, as well as in those with opportunistic infections of the central nervous system (p &lt; 0.0001). In particular, a significant decrease in fibronectin concentration in cerebrospinal fluid was observed in patients with cerebral toxoplasmosis and cryptococcal meningitis (p &lt; 0.0001). CONCLUSIONS--Because fibronectin can bind to several viruses, fungi, and protozoa, it is conceivable to suppose that the consumption of fibronectin in the cerebrospinal fluid of patients with neurological disorders may be related to the binding of fibronectin to HIV itself, or to viral proteins, or to organisms responsible for opportunistic infections.<\/jats:p>","DOI":"10.1136\/jcp.46.11.1039","type":"journal-article","created":{"date-parts":[[2007,6,9]],"date-time":"2007-06-09T00:50:46Z","timestamp":1181350246000},"page":"1039-1041","source":"Crossref","is-referenced-by-count":4,"title":["Cerebrospinal fluid concentration of fibronectin in patients with HIV-1 infection and central nervous system disorders."],"prefix":"10.1136","volume":"46","author":[{"given":"D","family":"Torre","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"C","family":"Zeroli","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"G","family":"Ferrario","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"G","family":"Bonetta","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"G P","family":"Fiori","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"R","family":"Martegani","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"239","published-online":{"date-parts":[[1993,11,1]]},"reference":[{"key":"ref_1","first-page":"111","article-title":"IProgr Hemostas Thromb","volume":"5","author":"Fibronectin, Mosher D.F.","year":"1980","unstructured":"Mosher DF. Fibronectin. IProgr Hemostas Thromb 1980; 5:111-57."},{"key":"ref_2","first-page":"95","article-title":"Fibronectin:current concepts of its structure and functions","volume":"1","author":"Rouslahti, E.; Engvall, E.; Hayman, E.G.","year":"1981","unstructured":"Rouslahti E, Engvall E, Hayman EG. Fibronectin:current concepts of its structure and functions. Collagen Res 1981;1:95-128.","journal-title":"Collagen Res"},{"key":"ref_3","first-page":"59","article-title":"Fibronectin increases the motility, phagocytosis and NBT (nitroblue tetrazolium)-reduction of granulocytes","volume":"8","author":"Jarstrand, C.; Ahlgren, T.; Berghem, L.","year":"1982","unstructured":"Jarstrand C, Ahlgren T, Berghem L. Fibronectin increases the motility, phagocytosis and NBT (nitroblue tetrazolium)-reduction of granulocytes. J Clin Lab Immunol 1982;8:59-63.","journal-title":"J Clin Lab Immunol"},{"key":"ref_4","doi-asserted-by":"crossref","first-page":"629","DOI":"10.1128\/IAI.47.3.629-637.1985","article-title":"Role of fibronectin in human monocyte and macrophage bactericidal activity","volume":"47","author":"Proctor, R.A.; Textor, J.A.; Vann, J.M.; Mosher, D.F.","year":"1985","unstructured":"Proctor RA, Textor JA, Vann JM, Mosher DF. Role of fibronectin in human monocyte and macrophage bactericidal activity. Infect Immun 1985;47:629-37.","journal-title":"Infect Immun"},{"key":"ref_5","first-page":"729","article-title":"Fibronectin concentration is decreased in plasma of severely ill patients with disseminated intravascular coagulation","volume":"91","author":"Mosher, D.F.; Williams, E.M.","year":"1978","unstructured":"Mosher DF, Williams EM. Fibronectin concentration is decreased in plasma of severely ill patients with disseminated intravascular coagulation. Jf Lab Clin Med 1978;91:729-35.","journal-title":"Jf Lab Clin Med"},{"key":"ref_6","doi-asserted-by":"crossref","first-page":"121","DOI":"10.1016\/S0140-6736(83)91760-9","article-title":"Functional hyposplenism during pneumococcal septicaemia","volume":"i:","author":"Boughton, B.J.; Simpson, A.; Chandler, S.","year":"1983","unstructured":"Boughton BJ, Simpson A, Chandler S. Functional hyposplenism during pneumococcal septicaemia. Lancet 1983;i: 121-2.","journal-title":"Lancet"},{"key":"ref_7","first-page":"487","article-title":"Plasma fibronectin in acute leukaemia","volume":"51","author":"Boughton, B.J.; Simpson, A.","year":"1982","unstructured":"Boughton BJ, Simpson A. Plasma fibronectin in acute leukaemia. BrJHaematol 1982;51:487-91.","journal-title":"BrJHaematol"},{"key":"ref_8","doi-asserted-by":"crossref","first-page":"560","DOI":"10.1136\/jcp.43.7.560","article-title":"Plasma fibronectin concentrations in patients with human immunodeficiency virus infection","volume":"43","author":"Torre, D.; Issi, M.; Sampietro, C.; Fiori, G.P.; Chelazzi, G.; Ferraro, G.","year":"1990","unstructured":"Torre D, Issi M, Sampietro C, Fiori GP, Chelazzi G, Ferraro G. Plasma fibronectin concentrations in patients with human immunodeficiency virus infection. J Clin Pathol 1990;43:560-2.","journal-title":"J Clin Pathol"},{"key":"ref_9","first-page":"595","article-title":"Demonstration of fibronectin in human cerebrospinal fluid","volume":"92","author":"Kuusela, P.; Vaheri, A.; Palo, J.; Ruoslahti, E.","year":"1978","unstructured":"Kuusela P, Vaheri A, Palo J, Ruoslahti E. Demonstration of fibronectin in human cerebrospinal fluid. J Lab Clin Med 1978;92:595-601.","journal-title":"J Lab Clin Med"},{"key":"ref_10","first-page":"138","article-title":"Increased intrathecal synthesis of fibronectin in bacterial and carcinomatous meningitis","volume":"82","author":"Weller, M.; Sommer, N.; Stevens, A.; Wietholter, H.","year":"1990","unstructured":"Weller M, Sommer N, Stevens A, Wietholter H. Increased intrathecal synthesis of fibronectin in bacterial and carcinomatous meningitis. Acta Neurol Scand 1990; 82:138-42.","journal-title":"Acta Neurol Scand"},{"key":"ref_11","doi-asserted-by":"crossref","first-page":"783","DOI":"10.1136\/jcp.44.9.783","article-title":"Cerebrospinal fluid concentration of fibronectin in meningitis","volume":"44","author":"Torre, D.; Zeroli, C.; Issi, M.; Fiori, G.P.; Ferraro, G.; Speranza, F.","year":"1991","unstructured":"Torre D, Zeroli C, Issi M, Fiori GP, Ferraro G, Speranza F. Cerebrospinal fluid concentration of fibronectin in meningitis. J Clin Pathol 1991;44:783-4.","journal-title":"J Clin Pathol"},{"key":"ref_12","doi-asserted-by":"crossref","first-page":"175","DOI":"10.1016\/0014-4827(86)90570-7","article-title":"Fibronectin is expressed by astrocyte cultures from embryonic and early postnatal rat brain","volume":"163","author":"Liesi, P.; Kirkwood, T.; Valieri, A.","year":"1986","unstructured":"Liesi P, Kirkwood T, Valieri A. Fibronectin is expressed by astrocyte cultures from embryonic and early postnatal rat brain. Exp Cell Res 1986;163:175-85.","journal-title":"Exp Cell Res"},{"key":"ref_13","doi-asserted-by":"crossref","first-page":"221","DOI":"10.1139\/m84-033","article-title":"In vitro binding of Candida albicans yeast cells to human fibronectin","volume":"30","author":"Skerl, K.G.; Calderone, R.A.; Segal, R.A.; Segal, E.; Sreevalsan, T.; Scheld, W.M.","year":"1984","unstructured":"Skerl KG, Calderone RA, Segal RA, Segal E, Sreevalsan T, Scheld WM. In vitro binding of Candida albicans yeast cells to human fibronectin. Can J Microbiol 1984;30:221-7.","journal-title":"Can J Microbiol"},{"issue":"4","key":"ref_14","doi-asserted-by":"crossref","first-page":"391","DOI":"10.1093\/clinids\/9.Supplement_4.S391","article-title":"Fibronectin in parasitic diseases","volume":"9","author":"Wyler, D.J.","year":"1987","unstructured":"Wyler DJ. Fibronectin in parasitic diseases. Rev Infect Dis 1987;9(Suppl 4):S391-S9.","journal-title":"Rev Infect Dis"},{"key":"ref_15","doi-asserted-by":"crossref","first-page":"876","DOI":"10.1128\/IAI.40.3.876-881.1983","article-title":"Interaction of viral envelope glycoproteins with fibronectin","volume":"40","author":"Julkunen, I.; Hautanen, A.; Keski-Oja, J.","year":"1983","unstructured":"Julkunen I, Hautanen A, Keski-Oja J. Interaction of viral envelope glycoproteins with fibronectin. Infect Immun 1983;40:876-81.","journal-title":"Infect Immun"}],"container-title":["Journal of Clinical Pathology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/syndication.highwire.org\/content\/doi\/10.1136\/jcp.46.11.1039","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,9,25]],"date-time":"2025-09-25T09:08:30Z","timestamp":1758791310000},"score":1,"resource":{"primary":{"URL":"https:\/\/jcp.bmj.com\/lookup\/doi\/10.1136\/jcp.46.11.1039"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[1993,11]]},"references-count":15,"journal-issue":{"issue":"11","published-online":{"date-parts":[[1993,11,1]]},"published-print":{"date-parts":[[1993,11]]}},"alternative-id":["10.1136\/jcp.46.11.1039"],"URL":"https:\/\/doi.org\/10.1136\/jcp.46.11.1039","relation":{},"ISSN":["0021-9746","1472-4146"],"issn-type":[{"type":"print","value":"0021-9746"},{"type":"electronic","value":"1472-4146"}],"subject":[],"published":{"date-parts":[[1993,11]]}}}